Analystreport

Viveve Medical Inc (NASDAQ: VIVE) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $10.00 price target on the stock.

Viveve Medical, Inc.  (VIVE) 
Last viveve medical, inc. earnings: 11/7 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: viveve.com